Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Annals of the Rheumatic Diseases
|
September 21, 2019
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
Jing He, Ruijun Zhang, Miao Shao, et al.
Nature Communications
|
April 21, 2026
Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial
Xia Zhang, Ruiling Feng, Yifan Wang, et al.
Immunity
|
December 16, 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
Mattia Bonsignori, Eric Scott, Kevin Wiehe, et al.
Science Translational Medicine
|
April 29, 2016
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages
Ruijun Zhang, Laurent Verkoczy, Kevin Wiehe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 17, 2016
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism
Todd Bradley, Guang Yang, Olga Ilkayeva, et al.
Journal of Virology
|
May 4, 2012
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages
M Anthony Moody, Nicole L Yates, Joshua D Amos, et al.
Cell Host & Microbe
|
September 12, 2014
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies
Thomas B Kepler, Hua-Xin Liao, S Munir Alam, et al.
The Journal of Experimental Medicine
|
April 7, 2010
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines
M Anthony Moody, Hua-Xin Liao, S Munir Alam, et al.
JAMA Network Open
|
November 10, 2022
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial
Jing He, Jiali Chen, Miao Miao, et al.
Immunity
|
December 20, 2014
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved
Kevin Wiehe, David Easterhoff, Kan Luo, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Annals of the Rheumatic Diseases
|
September 21, 2019
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
Jing He, Ruijun Zhang, Miao Shao, et al.
Nature Communications
|
April 21, 2026
Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial
Xia Zhang, Ruiling Feng, Yifan Wang, et al.
Immunity
|
December 16, 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
Mattia Bonsignori, Eric Scott, Kevin Wiehe, et al.
Science Translational Medicine
|
April 29, 2016
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages
Ruijun Zhang, Laurent Verkoczy, Kevin Wiehe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 17, 2016
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism
Todd Bradley, Guang Yang, Olga Ilkayeva, et al.
Journal of Virology
|
May 4, 2012
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages
M Anthony Moody, Nicole L Yates, Joshua D Amos, et al.
Cell Host & Microbe
|
September 12, 2014
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies
Thomas B Kepler, Hua-Xin Liao, S Munir Alam, et al.
The Journal of Experimental Medicine
|
April 7, 2010
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines
M Anthony Moody, Hua-Xin Liao, S Munir Alam, et al.
JAMA Network Open
|
November 10, 2022
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial
Jing He, Jiali Chen, Miao Miao, et al.
Immunity
|
December 20, 2014
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved
Kevin Wiehe, David Easterhoff, Kan Luo, et al.
Page
of 12